Lv1
40 积分 2023-02-03 加入
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
1天前
已完结
Advances in the clinical research on systemic small-molecule drugs and biologics for the treatment of alopecia areata
8天前
已关闭
Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion
16天前
已完结
Gain-of-function PPM1D mutations attenuate ischemic stroke
28天前
已完结
ICH M12 Drug Interaction Studies: Summary of the Efforts to Achieve Global Convergence
1个月前
已完结
Future directions in drug-drug interaction evaluations: Industry perspective on the ICH M12 guidance
1个月前
已完结
AHB-137, a novel and potent hepatitis B virus antisense oligonucleotide with a favorable preclinical pharmacokinetics and safety profile
2个月前
已完结
Targeting THR-β for MASLD Treatment: Current Progression and Emerging Prospects
2个月前
已完结
Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
2个月前
已完结
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development
2个月前
已完结
皖公网安备34019202002308
